Creyon Bio Names Industry Veteran Serge Messerlian as CEO to Drive Growth and Partnerships
Creyon Bio Names Industry Veteran Serge Messerlian as CEO to Drive Growth and Partnerships Creyon Bio, a biotechnology company pioneering the use of artificial intelligence in oligonucleotide therapy development, has…
Novocure’s Optune Lua Earns CE Mark Approval for Treating Metastatic Non-Small Cell Lung Cancer
Novocure’s Optune Lua® Earns CE Mark Approval for Treating Metastatic Non-Small Cell Lung Cancer In a significant development for the treatment of advanced lung cancer, Novocure announced that its innovative…
Novocure to Present Late-Breaking Phase 3 PANOVA-3 Data for TTFields in Pancreatic Cancer at ASCO 2025
Novocure to Present Late-Breaking Phase 3 PANOVA-3 Data for TTFields in Pancreatic Cancer at ASCO 2025 Novocure, a global leader in innovative cancer treatments, has announced that it will present…
Zai Lab to Present Phase 1 Data on DLL3-Targeted ADC ZL-1310 at ASCO 2025
Zai Lab to Present Phase 1 Data on DLL3-Targeted ADC ZL-1310 at ASCO 2025 Zai Lab Limited , a leading innovative biopharmaceutical company, announced today that it will present updated…
Pfizer Champions a New Era in Personalized Cancer Care at ASCO 2025 Annual Meeting
Pfizer Champions a New Era in Personalized Cancer Care at ASCO 2025 Annual Meeting Pfizer Inc. (NYSE: PFE), a global leader in biopharmaceutical innovation, announced its robust presence at the…
Verastem Gets U.S. IND Clearance for KRAS G12D Inhibitor VS-7375, Paving Way for Phase 1/2a Trial in Solid Tumors
Verastem Gets U.S. IND Clearance for KRAS G12D Inhibitor VS-7375, Paving Way for Phase 1/2a Trial in Solid Tumors Verastem Oncology (Nasdaq: VSTM), a Boston-based biopharmaceutical company at the forefront…
CN Bio and Pharmaron Forge Long-Term Global Partnership for OOC Tech Development
CN Bio and Pharmaron Forge Long-Term Global Partnership for OOC Tech Development In a significant stride toward revolutionizing preclinical drug development, CN Bio, a leading innovator in Organ-on-a-Chip (OOC) technologies,…
Halda Therapeutics Names Dr. Eyal Attar as New Chief Medical Officer
Halda Therapeutics Names Dr. Eyal Attar as New Chief Medical Officer Halda Therapeutics, a clinical-stage biotechnology company pioneering a new class of cancer therapeutics, has announced the appointment of Dr.…
FDA Grants Breakthrough Status to BrainChild Bio’s CAR T Therapy for Pediatric Brain Tumors
FDA Grants Breakthrough Status to BrainChild Bio’s CAR T Therapy for Pediatric Brain Tumors BrainChild Bio, Inc., a clinical-stage biotechnology company at the forefront of neuro-oncology cell therapy innovation, has…
EditCo Bio and Promega Team Up to Advance Cell-Based Research
EditCo Bio and Promega Team Up to Advance Cell-Based Research In a pivotal move set to reshape the landscape of functional genomics and cell engineering, EditCo Bio, Inc. has announced…
TNF Pharmaceuticals and Renova Health Harness AI to Fast-Track Drug Discovery
TNF Pharmaceuticals and Renova Health Harness AI to Fast-Track Drug Discovery In a significant advancement for data-driven drug development, TNF Pharmaceuticals has announced a strategic collaboration with Renova Health to…
Secretome Therapeutics Names Dr. Marshelle Smith Warren as New Chief Medical Officer
Secretome Therapeutics Names Dr. Marshelle Smith Warren as New Chief Medical Officer Secretome Therapeutics, a pioneering clinical-stage biotechnology company dedicated to advancing therapies derived from neonatal cardiac progenitor cells (nCPCs),…